Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Journal Title: Journal of Vaccines and Immunology - Year 2016, Vol 2, Issue 1
Abstract
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating and vaccine strains of viruses may compromise the efficacy of vaccines. Methods: In this study, a current circulating NDV was attenuated by mutations of multiple basic amino acid motif of fusion cleavage site 112RRQKGF117 based on reverse genetic techniques. The recombinant virus was prepared as an inactivated vaccine to test its efficacy and compared with a commercial LaSota NDV vaccine on SPF chickens. Results: All vaccinated chickens survived by the end of the study. By contrast, the unvaccinated chickens were all dead before 5 days post-challenge (DPC). Compared to commercial LaSota vaccine, the experimental inactivated vaccine elicited earlier and higher titer of HI antibodies and had reduced titer and duration of virus shedding after challenge. Conclusion: The experimental inactivated NDV vaccine may work as a promising vaccine candidate to control the disease.
Authors and Affiliations
Cheng Yi, Sheng Dongbei, Li Xiangdong, Hong Sumei, Guo Lixia, Zhao Shasha, Yuan Yue, Xue Jingjing, Tian Hui, Ren Yipin, Liu Wujie
Keywords
Related Articles
- EP ID EP553750
- DOI 10.17352/jvi.000016
- Views 84
- Downloads 0
The Role of Endoplasmic Reticulum Aminopeptidase 1 Biology in Immune Evasion by Tumours
Expression of MHC I at the cell surface is essential for presenting peptides to circulating cytotoxic T cells. Interference with a number of components of the antigen processing machinery is an immune evasion mechanism t...
Travel Vaccination
With increased globalization, the international boundaries between countries are diminished. Number of worldwide activities such as tourism, expansion of industry to multinational level, migrant employment, civilized eff...
IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1
Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses. Also, exper...
Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating a...
Mammalian Parasitic Vaccine: A Consolidated Exposition
Parasites are highly prevalent in livestock worldwide and infect over one fourth of the human population also. Parasites are successful in evading host immune responses, and vaccination can prove to be an effective way t...